David James Lennon
Chief Executive Officer at Whitehawk Therapeutics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Whitehawk Therapeutics Inc., 2 years.
Whitehawk Therapeutics Inc.
Director · CHIEF EXECUTIVE OFFICER
Chief executive roles
Whitehawk Therapeutics Inc.
· Chief Executive Officer
Since October 2023
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 14, 2026 | Whitehawk Therapeutics Inc. | Grant or award | +51,021 | $3.92 | $200,002 |
| Apr 9, 2026 | Whitehawk Therapeutics Inc. | Open-market sale | −14,500 | $3.38 | $49,010 |
| Apr 8, 2026 | Whitehawk Therapeutics Inc. | Open-market sale | −63,945 | $3.40 | $217,413 |
| Apr 7, 2026 | Whitehawk Therapeutics Inc. | Open-market sale | −94,087 | $3.43 | $322,718 |
| Apr 6, 2026 | Whitehawk Therapeutics Inc. | Open-market sale | −102,395 | $3.51 | $359,406 |
| Apr 2, 2026 | Whitehawk Therapeutics Inc. | Open-market sale | −26,858 | $3.48 | $93,466 |
| Apr 1, 2026 | Whitehawk Therapeutics Inc. | Option exercise | +775,828 | — | — |
| Mar 2, 2026 | Whitehawk Therapeutics Inc. | Open-market sale | −5,100 | $3.31 | $16,881 |
| Mar 1, 2026 | Whitehawk Therapeutics Inc. | Option exercise | +16,250 | — | — |
| Mar 3, 2025 | Whitehawk Therapeutics Inc. | Open-market sale | −5,690 | $2.35 | $13,372 |
| Mar 1, 2025 | Whitehawk Therapeutics Inc. | Option exercise | +16,250 | — | — |
| Oct 3, 2024 | Whitehawk Therapeutics Inc. | Open-market sale | −9,689 | $1.94 | $18,797 |
| Oct 2, 2024 | Whitehawk Therapeutics Inc. | Option exercise | +32,558 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.